Skip to content

Veracyte VCYT Contingent Consideration Liability (Non-Current)

Contingent Consideration Liability (Non-Current) at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$103.2M
Abbott logo
AbbottABT
$1M-97.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$72.65M
Labcorp Holdings logo
Labcorp HoldingsLH
Idexx Laboratories logo
Idexx LaboratoriesIDXX

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's contingent consideration liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's contingent consideration liability (non-current)?
Veracyte (VCYT) reported contingent consideration liability (non-current) of $257K in Q1 2026.
How has Veracyte's contingent consideration liability (non-current) changed year-over-year?
Veracyte's contingent consideration liability (non-current) decreased by 54.9% year-over-year, from $570K to $257K.
What is the long-term trend for Veracyte's contingent consideration liability (non-current)?
Over 5 years (2020 to 2025), Veracyte's contingent consideration liability (non-current) has grown at a -49.2% compound annual growth rate (CAGR), from $7.59M to $257K.
What does contingent consideration liability (non-current) mean?
This represents the long-term portion of estimated future payments owed to sellers following an acquisition, contingent upon the achievement of specific performance milestones or financial targets. It reflects the fair value of obligations expected to be settled beyond the next twelve months. Investors monitor this to assess potential future cash outflows and the company's success in integrating acquired businesses against pre-defined growth objectives.